Hainan Haiyao Co., Ltd. (SHE:000566)

115.36% (1Y)

Market Cap	8.15B
Revenue (ttm)	834.28M
Net Income (ttm)	-1.58B
Shares Out	1.30B
EPS (ttm)	-1.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,751,388
Average Volume	71,143,358
Open	6.23
Previous Close	6.28
Day's Range	6.20 - 6.43
52-Week Range	2.84 - 7.40
Beta	0.87
RSI	55.86
Earnings Date	Aug 27, 2025

About Hainan Haiyao

Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company develops intermediates, APIs, innovative chemical drugs, modern Chinese medicines, biological drugs, cellular immunity products, and high-end medical devices. It offers its products in various forms, such as pills, tablet granules, tincture fluid extracts, powders, syrups, soft capsule raw materials, powder injections, and health foods in various antibiotic series, gastrointestinal medication series, anti-tumor me...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 2,003
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000566

Financial Performance

In 2024, Hainan Haiyao's revenue was 990.70 million, a decrease of -33.00% compared to the previous year's 1.48 billion. Losses were -1.53 billion, 1332.3% more than in 2023.